EUCTR2013-004565-14-DE进行中（未招募）1 期
Extension Study of XLHED-Affected Male Subjects treated with EDI200 in Protocol ECP-002
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Subjects must meet all of the following criteria to be enrolled:
- •1.Subject received at least one dose of EDI200 in the neonate study ECP-002
- •2.Written informed consent of parent(s)
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 10
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects who meet any of the following criteria may not be enrolled in this study:
- •1.Medically-significant postnatal complications or congenital anomalies outside of those considered to be associated with the diagnosis of XLHED
- •2.Major protocol violations during enrollment in study ECP-002 as determined by the Sponsor
研究者
相似试验
进行中（未招募）
1 期
Extension Study of XLHED-Affected Male Subjects treated with EDI200 in Protocol ECP-002X-linked hypohidrotic ectodermal dysplasia (XLHED) is caused by inherited defects in the ectodysplasin (EDA) gene that disrupt synthesis and/or function of the primary translational product EDA-A1. The absence of normal EDA-A1 expression results in sweat and secretory gland hypoplasia predisposing XLHED-affected infants to serious a potentially life-threatening hyperthermia and pneumonia.MedDRA version: 18.0Level: LLTClassification code 10072592Term: Hypohidrotic ectodermal dysplasiaSystem Organ Class: 100000004850EUCTR2013-004565-14-FREdimer Pharmaceuticals, Inc.10
撤回
不适用
A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHEDXLHEDNCT03912792Dermelix Biotherapeutics, LLC.
已完成
不适用
Evaluation of Phenotypic and Genetic Properties in Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia (ECP-012)X-linked Hypohidrotic Ectodermal DysplasiaHypohidrotic Ectodermal DysplasiaNCT01629927Edimer Pharmaceuticals30
已完成
不适用
Investigation of Chronic Inflammatory Processes in Male Individuals With Hypohidrotic Ectodermal DysplasiaX-linked Hypohidrotic Ectodermal DysplasiaNCT01308333University Hospital Erlangen38
已完成
不适用
X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED) Carrier Outlook Toward Reproduction SurveyHypohidrotic Ectodermal DysplasiaX-Linked Hypohidrotic Ectodermal DysplasiaNCT01398813Edimer Pharmaceuticals500